JOSH JIN, Ph.D.
Senior Investment Manager
Josh Jin, Ph.D., is a Senior Investment Manager with Lilly Asia Ventures (LAV). Prior to joining LAV, Josh was a Consultant at Boston Consulting Group (BCG) Shanghai office, helping biopharma companies and private equity firms on various corporate strategy and equity investment related topics. Prior to BCG, Josh worked at Syneos Health New York office as an Associate Consultant on pricing and market access. Josh holds Ph.D. in Genetics from Yale University and B.S. in Biotechnology from Fudan University.
Company
Shanghai
Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Hong Kong
Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong
US
2730 Sand Hill Road, Suite 130, Menlo Park, CA